Cats and dogs are severely underdiagnosed and overprescribed with antibiotics, due to the lack of a pathogen detection system that can deliver results during the patient’s visit. In many cases, it has proven simpler to prescribe a best-guess antibiotic based on symptoms, rather than implementing precision medication techniques. This leads to animals suffering with treatable illnesses longer than necessary, and higher ultimate cost to the pet owner by the time the pet has its pathogen cleared. The companion animal health arena could greatly benefit from a rapid diagnostic platform that offers a diverse platform of pathogen detection assays, which would encourage precision medicine in treating animals.
Through multiple industry partnerships and efficient internal R&D, FastDetect is on the path to developing an extensive portfolio of viral and bacterial detection assays. Each assay is projected to display similar high accuracy and short time-to-result, enabling veterinarians to properly screen animals on-site during their visit and prescribe the appropriate treatment based on test results. FastDetect can thus make a significant positive impact on antibiotic stewardship worldwide.